Aging and Quality of Life: Comparison
Please note this is a comparison between Version 2 by Jason Zhu and Version 1 by Shinichi Noto.

The aging of the world’s population and the health problems accompanying it are becoming increasingly severe. Healthcare policies in developed countries focus on how to prevent and treat diseases associated with aging and how to maintain quality of life. Typical age-related diseases include deafness, cataracts, osteoarthritis, chronic obstructive pulmonary disease, diabetes mellitus, and dementia. Although the mechanisms by which these diseases develop differ, they are all caused by the accumulation of molecular and cellular damage over time.

  • aging
  • older adults
  • lifestyle-related diseases

1. Introduction

An aging population has various implications on health, which in turn has a significant impact on medical care and health policy. According to the World Health Organization (WHO) [1], by 2030, one in six people worldwide will be aged 60 years or older. Furthermore, the population aged 60 years and older is expected to increase from 1 billion in 2020 to 1.4 billion in 2030. In addition, by 2050, this population is expected to double (2.1 billion). Similarly, the number of people aged 80 years and older is expected to triple between 2020 and 2050 and reach 426 million. This shift in population distribution toward older adults, known as population aging, began in high-income countries. However, it is most advanced in Japan, where 30% of the population is already aged 60 years or older. Moreover, this aging has further extended to low- and middle-income countries. It is estimated that by 2050, two-thirds of the world’s population aged 60 and older will live in low- and middle-income countries. The effects of this aging population are causing great concern for human health, and society requires major changes. Of particular importance is the question of how to stay healthy during an extended life expectancy.
According to the Organization for Economic Co-operation and Development (OECD) [2], the average life expectancy after 65 years in member countries was approximately 20 years. Furthermore, it was the longest for Japanese women (25 years). The average life expectancy is increasing every year and has the advantage of providing opportunities to pursue new activities, such as further education, new careers, and long-neglected passions. However, it also leads to the emergence of several complex health conditions, commonly known as geriatric syndromes. The most common of these health conditions is frailty, a syndrome characterized by reduced functional capacity and increased vulnerability to disease. It is associated with various adverse health outcomes, including mortality, falls, fractures, and institutionalization [3]. Another typical health condition of geriatric syndromes is sarcopenia, estimated to affect 10% to 16% of the world’s older adults. It is an old condition characterized by progressive muscle mass and function loss and is associated with various adverse health outcomes [4].
However, how meaningful the remainder of one’s life is after aging is based on the maintenance of good health. Hence, it is important to avoid falling sick and to maintain or improve one’s quality of life even when one falls sick. The challenge for those involved in geriatric and community health care is to prevent the development of geriatric syndromes in the aging population and to take approaches to improve health-related quality of life (HRQOL), even when such conditions do occur.

2. Negative Effects of Aging on Health

At the biological level, aging results from the accumulation of molecular and cellular damage over time. This results in a gradual decline in physical and mental capacities and an increase in the risk of disease. In addition to biological changes, retirement, loss of purpose in life, relocation to more suitable housing, and the death of a friend or partner also often result in psychological damage. In addition to physical and mental decline, social restrictions also result in a diminished quality of life.

2.1. Cellular Changes

First, with aging, the oxygen supply to all organs and tissues and the partial pressure of oxygen in tissues decrease, resulting in hypoxia. It is then thought to be involved in the development of inflammatory diseases, tumors, and cardiac disease [5]. Excessive production of reactive oxygen species also leads to the destruction of nucleic acids and proteins, thereby altering cellular structures and functional outcomes. The detrimental effect on the organism caused by such oxidative reactions is called oxidative stress. It causes aging and chronic degenerative diseases such as cardiovascular disease, diabetes mellitus, and chronic kidney disease, Alzheimer’s disease (AD), Parkinson’s disease, and other neurodegenerative diseases [6]. Advanced glycation end-products (AGEs) is a general term for heterogeneous derivatives produced by non-enzymatic reactions of reducing sugars with proteins. It has recently been suggested that AGEs are involved in the pathogenesis of chronic hyperglycemia and age-related diseases. The accumulation of AGEs and their derivatives can modify proteins and could promote aging by activating several inflammatory signaling pathways via AGEs-specific receptors [7].

2.2. Chromosome Changes

Telomeres are structures at the ends of chromosomes that shorten with each cell division. Shortening of telomeres, which are specialized nucleoprotein structures at the ends of linear chromosomes, has been linked to aging [8]. When telomeres do not function, chromosomes lose their protective structure, and fusion and breakage phenomena occur, leading to further genomic instability such as cell arrest and death [9]. Additionally, impairment of the telomere function, coupled with impairment of the senescence/apoptosis response, causes chromosomal instability [10].

2.3. Psychological Changes

In addition to the above-mentioned physiological changes, various age-related events negatively impact mental health. Loss of a role or purpose in life after retirement, the independence of children, or the death of a partner or good friend can cause psychological harm [11,12][11][12]. Except for those who can retire with sufficient savings, many older adults could experience financial hardship due to a decrease in income [13]. It is easily perceived that these factors can negatively impact health.

3. Diseases Likely to Occur with Age

This section describes various diseases that are more likely to develop with aging and their impact on HRQOL of older adults. Hearing loss, cataracts, back and neck pain, osteoarthritis, osteoporosis, chronic obstructive pulmonary disease, diabetes, depression, and dementia are common problems in older adults. Older adults are also more susceptible to lifestyle-related diseases, such as stroke, coronary artery disease, and cancer. Furthermore, as people age, they are more likely to experience multiple diseases simultaneously. Hearing loss is the third most common chronic health condition that affects older adults. Age-related hearing loss affects one in three adults over the age of 65 years. Sensorineural hearing loss related to loss of outer hair cells was reported to be present in most adults patients aged 85 years and older [14]. It is caused by exogenous and endogenous factors, such as heredity, aging, and exposure to noise and toxins [15]. Abraham et al. [16] also reported the danger of hiding hearing-impaired in older adults among patients with dementia. Cataract is the most common cause of blindness worldwide. A report stated that more than 70% of people over the age of 80 years had clinically significant age-related cataracts [17]. Another study reported that cataract patients had an increased risk of dementia if they did not undergo surgical treatment [18]. There is no doubt that cataract is a serious disease, as it has been reported that older adults are more susceptible to the impact of cataracts on their HRQOL [19]. Osteoarthritis is another common cause of disease in the aging population. Joints of the lower extremities, which generally bear most of the body weight, are most often affected by osteoarthritis. In particular, knee osteoarthritis is a presumed risk factor for several medical conditions, including cardiovascular disease and falls [20]. In contrast, degenerative changes in the joints of the upper extremities are equally common, predisposing to osteoarthritis in shoulder, elbow, and hand joints [21]. Osteoporosis is a bone metabolic disease that women are typically at higher risk of developing than men. A reason for the higher incidence of osteoporosis in women is that production of estrogen by their ovaries becomes variable during perimenopause and ceases post-menopause. Notably, estrogen promotes the activity of osteoblast cells that produce bone [22]. Osteoporosis is also a predisposing factor for increased risk of hip, spine, and other skeletal site fractures; the clinical impact and economic burden of such injuries has contributed towards advocacy for periodic physical examinations for older women that prompt appropriate interventions [23]. Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide. The greatest risk factors include smoking and aging. COPD develops after the age of 60 years and its pathogenesis is characterized by fibrosis and remodeling of the small airways, accompanied by destruction of the lung parenchyma [24]. Furthermore, its pathological mechanisms include multiple aging pathways, including telomere loss, epigenetic changes, altered nutrient sensing, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, and chronic inflammation [25]. In nursing homes, residents with COPD are more likely to have comorbid heart failure than those without COPD [26]. It is necessary to address. Cancer is a clump of abnormal cells arising from normal cells, and cancer cells appear when two to ten genes of normal cells are damaged. Since this is induced gradually over a long period, aging plays a significant role in its development. The effects of aging have been noted in various cancers, including liver [27] and breast cancer [28]. The peak incidence of cancer is reported to be between 65 and 74 years of age, and the number of older adults diagnosed with cancer is expected to increase significantly with the aging of the population [29]. There are also reports that chronic psychological stress precipitates death from cancer [30]. On the other hand, there is concern about the increasing proportion of frail cancer survivors [31], and how to coexist with cancer is an important issue for an aging society. In 2021, 537 million people worldwide were affected by diabetes. Furthermore, this number is expected to increase due to aging population [32]. Diabetes mellitus is a disease associated with end-organ damage, dysfunction, and failure of the retina, kidneys, nervous system, heart, and blood vessels. Furthermore, lifestyle influences the development of diabetes, especially type 2 diabetes. Aging has been pointed out as a factor that decreases the quality of life of diabetic patients [33]. Recently, research has also focused on the relationship between diabetes and age-related cognitive function. According to a large prospective study in the United States, women were more susceptible to diabetes-related cognitive decline with advancing age than men [34]. According to the National Institute on Aging-Alzheimer’s Association, Alzheimer’s disease assumes that β-amyloid deposition is an etiological factor. Furthermore, its neuropathological diagnosis is based on the coexistence of senile plaques (SPs) and neurofibrillary tangles (NFTs), which are designated as neuropathological changes of Alzheimer’s disease. NFTs are found in approximately 85% and 97% of individuals aged 65 and 80, respectively. Meanwhile, SPs occur in 30% and 50–60% at age 65 and 80, respectively. Alzheimer’s disease, a disease of the aging process [35], is the most common form of age-related dementia. It is characterized by progressive memory loss and cognitive impairment. Adult hippocampal neurogenesis (AHN) is known to decline rapidly in patients with Alzheimer’s disease [36]. Differences between urban and rural areas have been noted. Patients with dementia in rural areas have higher mortality rates, lower consultation rates, higher doses of antipsychotic medications, and lower use of home care services than those in urban areas [37]. Furthermore, a cohort study of an aging rural Japanese population found that the risk factors for decreased independence included hypertension, diabetes, being overweight, chronic kidney disease, current smoking, and history of stroke, heart disease, and cancer [38]. Stroke may be the greatest risk factor for decreased activities of daily living (ADL), represented by eating and toileting activities, and HRQOL, as it often results in hemiplegia. Chronic kidney and heart disease also reduce activity and inevitably worsen quality of life. Hypertension, diabetes, obesity, chronic kidney disease, smoking addiction, stroke, and heart disease are lifestyle-related diseases with causal mechanisms distinct to cellular senescence caused by aging, such as cellular and genetic changes described in the previous section. These diseases typically develop from high-calorie diets, lack of exercise, and excessive alcohol consumption; additionally, as life expectancy increases and such habits are prolonged, the risk of developing these diseases increases exponentially. In summary, the risk of developing lifestyle-related diseases increases with age unless lifestyle habits are changed [39,40,41][39][40][41]. The following section summarizes the impact of aging on HRQOL and reviews the relationship between these diseases.

4. Relationship between Aging, Disease, and HRQOL

Aging reduces mental and physical function and decreases the ability to perform activities of daily living and HRQOL. HRQOL is a useful outcome measure for treatment, especially in older patients whose physical and mental functions are difficult to improve once they have declined. In particular, the health state utility value is a centralized health-related quality of life score, with 0 indicating death and 1 indicating perfect health, so that scores can be compared between different diseases and across countries. Preference-based measures (PBMs) are typically used to measure the health state utility value. Of the many PBMs, the Euro QOL five-dimensional questionnaire (EQ-5D) is the most widely used PBM worldwide, because it has been translated into various languages and for which country-specific scoring algorithms are available. Health data from Japan [46][42], which has the world’s oldest population, show a clear decline in HRQOL after the age of 80. Subjective symptoms, such as back pain, stiff shoulders, and arthritic pain, decreased their HRQOL. Interestingly, Yang et al. [48][43] found that in China, three aspects of the EQ-5D-5L were affected by aging: mobility, daily life, and anxiety/depression. In contrast, in a study of older adult subjects in European countries using the EQ-5D-3L [51][44], the scores decreased with age, but problems with pain and discomfort were most frequent (36–73%, any problems), and those with self-care practices were least frequent (3–31%, any problems). The first of these is hearing loss. The impact of age-related hearing loss on HRQOL has been reported to cause decreased communication and social and emotional interactions [52][45]. Communication is an important function and means for connecting people. Even if the speech function is unaffected, smooth communication will be difficult if sound recognition is impaired. For hearing loss in older adults, hearing aids were reported to improve quality of life [53][46]. However, hearing aids are more expensive than eyeglasses; therefore, their cost should be considered. Like hearing, vision is one of the most important senses in human life; it is used in communication, but more so for the enrichment and safety of one’s life. However, this function declines with age. In most cases, farsightedness can be compensated for by wearing graduated glasses. However, the impact of cataracts and glaucoma on HRQOL is more severe because these conditions cannot be improved by purchasing devices such as glasses. Tan et al. [54][47] reported that vision-related quality of life was significantly impaired in patients with cataract with high myopia. Furthermore, it was significantly improved after cataract surgery. Surgery for cataracts has also been reported to improve vision-related quality of life in both the first and second surgeries [55][48]. As people age, bone and joint deformities are more likely to occur owing to bone loss and wear-and-tear of cartilage and other tissues. Osteoarthritis of the knee joint is one such condition. A large Korean study reported higher odds ratios for depressed mood, psychological distress, and suicidal ideation, in addition to mobility impairment and pain in those with osteoarthritis [56][49]. The EQ-5D, a utility value scale, has also been shown to be effective in assessing the impact of changes in chronic pain related to osteoarthritis on HRQOL, even though it does not have excellent sensitivity or responsiveness for all diseases [57][50]. The relationship between COPD and quality of life was reported to be determined by specific factors, such as gender, severity index, pulmonary function parameters, body mass index, smoking, symptoms, complications, depression, anxiety, and exacerbations [58][51]. Lung function declines with age and this can facilitate the onset of COPD. Persistently poor lifestyle habits, such as obesity and smoking, can also contribute to the development of COPD. COPD decreases lung capacity, which consequently reduces the extent of activities in daily life, further diminishing HRQOL. A study that examined the effect of lung volume reduction surgery for COPD on HRQOL indices showed improvement in quality of life as measured by the 36-item Short Form Survey (SF-36) and EQ-5D [59][52]. Type 2 diabetes mellitus develops when a relative deficiency of insulin ensues from a genetic predisposition to insufficient insulin production, compounded by insulin resistance arising from an environmental predisposition to a poor lifestyle. In particular, an accumulation of fat in the liver and muscles due to lifestyle disorders, such as a high-fat diet, overeating, and a lack of exercise, reduces insulin function. A large European study demonstrated that frailty is more common in older adult diabetics, who tend to be depressed in addition to having low self-health ratings [60][53]. A study of a cohort of diabetic patients in China reported a correlation between cognitive decline and quality of life [61][54]. Thus, older adult patients with diabetes not only require insulin injections, but also experience a variety of adverse effects that persist throughout their lives and do not improve their HRQOL. There have been numerous reports on the relationship between cancer treatment and HRQOL. This is because the side effects of chemotherapy have a significant impact on HRQOL. According to a study by Carelle et al. [62][55] the cancers most frequently affected by chemotherapy were breast, gastrointestinal, lung, and ovarian cancers, with the most severe side effects being “impact on family and partner”, the second most serious being “alopecia”, and the third most serious being “fatigue”. The impact of hormone therapy on HRQOL has also been reported [63][56]. Although targeted anti-human epidermal growth factor receptor 2 (HER2) agents have shown promising efficacy in older patients, it has been noted that the impact on HRQOL should be considered when extending treatment [64][57]. In any case, a HRQOL perspective is essential in evaluating cancer treatment in older adults. One of the most worrisome health conditions associated with aging is dementia, typified by Alzheimer’s disease. Dementia is primarily characterized by negative symptoms such as memory and attention impairment. As the disease progresses, positive mental symptoms, such as delusions and personality disorders, gradually become dominant. A systematic review on the relationship between dementia and quality of life found that self-assessment by patients themselves was higher than that by caregivers or other proxies [65][58]. This is because as dementia progresses, the patient’s self-insight declines and they lack a sense of awareness of the disease. It is also important to assess the decline in caregivers’ quality of life. Furthermore, it has been found that caregivers’ quality of life declines as the patient’s severity of dementia worsens [66][59]. When discussing the decline in HRQOL due to dementia, it is as important to pay attention to and possibly measure the QOL of caregivers, such as spouses and children, because caring for dementia patients can be physically and emotionally demanding. Heart disease and stroke are representative diseases caused by aging and lifestyle-related deteriorations. Both are caused by arteriosclerosis and hypertension, in which blood vessels narrow owing to deposits of cholesterol and other substances, resulting in poor blood flow. Cerebral infarction is caused by arteriosclerosis; however, in some cases, atrial fibrillation may result in a major cardiogenic cerebral embolism. When older people suffer from heart disease or have a stroke, their activity level decreases and their HRQOL declines. Golicki et al. [67][60] showed that the worst poststroke condition, as indicated by the Modified Rankin Scale, has a negative utility value. Although HRQOL does not decrease significantly in patients with cardiac disease, it is reported to be lower than that in healthy subjects [68][61]. Although some improvement can be expected with rehabilitation, these patients do not recover to a state of health as that before their illness. Therefore, a shift is being made in Japan from “medical treatment to cure”, which focuses on organ-specific treatment, to “medical treatment to cure and support”, which prioritizes treatment to maximize patients’ quality of life [69][62]. On the other hand, for these lifestyle-related diseases, not only have individual personality and temperament been noted as contributing influences, but also pollution of soil, water, air, and noise, as well as other environmental risks factors such as climate change, unhealthy urban design (e.g., lack of green space), unhealthy lifestyle habits, and psychosocial stress [70][63].

References

  1. World Health Organization. Global Strategy and Action Plan on Ageing and Health. 2017. Available online: https://www.who.int/publications/i/item/global-strategy-and-action-plan-on-ageing-and-health (accessed on 17 April 2023).
  2. OECD. Health at a Glance 2021: OECD Indicators; OECD Publishing: Paris, France, 2021.
  3. Hakeem, F.F.; Maharani, A.; Todd, C.; O’Neill, T.W. Development, validation and performance of laboratory frailty indices: A scoping review. Arch. Gerontol. Geriatr. 2023, 111, 104995.
  4. Yuan, S.; Larsson, S.C. Epidemiology of sarcopenia: Prevalence, risk factors, and consequences. Metabolism 2023, 144, 155533.
  5. Dzhalilova, D.S.; Makarova, O.V. The Role of Hypoxia-Inducible Factor in the Mechanisms of Aging. Biochemistry 2022, 87, 995–1014.
  6. Leyane, T.S.; Jere, S.W.; Houreld, N.N. Oxidative Stress in Ageing and Chronic Degenerative Pathologies: Molecular Mechanisms Involved in Counteracting Oxidative Stress and Chronic Inflammation. Int. J. Mol. Sci. 2022, 23, 7273.
  7. Frimat, M.; Daroux, M.; Litke, R.; Nevière, R.; Tessier, F.J.; Boulanger, E. Kidney, heart and brain: Three organs targeted by ageing and glycation. Clin. Sci. 2017, 131, 1069–1092.
  8. Revy, P.; Kannengiesser, C.; Bertuch, A.A. Genetics of human telomere biology disorders. Nat. Rev. Genet. 2023, 24, 86–108.
  9. Borges, G.; Criqui, M.; Harrington, L. Tieing together loose ends: Telomere instability in cancer and aging. Mol. Oncol. 2022, 16, 3380–3396.
  10. Frias, C.; Pampalona, J.; Genesca, A.; Tusell, L. Telomere dysfunction and genome instability. Front. Biosci. 2012, 17, 2181–2196.
  11. Haslam, C.; Lam, B.C.P.; Ghafoori, E.; Steffens, N.K.; Haslam, S.A.; Bentley, S.V.; Cruwys, T.; La Rue, C.J. A longitudinal examination of the role of social identity in supporting health and well-being in retirement. Psychol. Aging 2023.
  12. Stahl, S.T.; Emanuel, J.; Albert, S.M.; Dew, M.A.; Schulz, R.; Robbins-Welty, G.; Reynolds, C.F., 3rd. Design and Rationale for a Technology-Based Healthy Lifestyle Intervention in Older Adults Grieving the Loss of a Spouse. Contemp. Clin. Trials Commun. 2017, 8, 99–105.
  13. Shu, Z.; Xiao, J.; Dai, X.; Han, Y.; Liu, Y. Effect of family “upward” intergenerational support on the health of rural elderly in China: Evidence from Chinese Longitudinal Healthy Longevity Survey. PLoS ONE 2021, 16, e0253131.
  14. Göthberg, H.; Skoog, I.; Tengstrand, T.; Magnusson, L.; Hoff, M.; Rosenhall, U.; Sadeghi, A. Pathophysiological and Clinical Aspects of Hearing Loss Among 85-Year-Olds. Am. J. Audiol. 2023, 32, 440–452.
  15. White, K.; Someya, S. The roles of NADPH and isocitrate dehydrogenase in cochlear mitochondrial antioxidant defense and aging. Hear. Res. 2023, 427, 108659.
  16. Abraham, A.G.; Hong, C.; Deal, J.A.; Bettcher, B.M.; Pelak, V.S.; Gross, A.; Jiang, K.; Swenor, B.; Wittich, W. Are cognitive researchers ignoring their senses? The problem of sensory deficit in cognitive aging research. J. Am. Geriatr. Soc. 2023, 71, 1369–1377.
  17. Hambisa, M.T.; Dolja-Gore, X.; Byles, J.E. A longitudinal analysis of factors associated with age-related cataract among older Australian women: A cohort study of 7851 older Australian women 79–90 years. Ir. J. Med Sci. 2022, 192, 1525–1536.
  18. Ma, L.-Z.; Zhang, Y.-R.; Li, Y.-Z.; Ou, Y.-N.; Yang, L.; Chen, S.-D.; Dong, Q.; Feng, J.-F.; Cheng, W.; Tan, L.; et al. Cataract, cataract surgery, and risk of incident dementia: A prospective cohort study of 300,823 participants. Biol. Psychiatry 2022, 93, 810–819.
  19. He, M.; Xu, J.; Li, S.; Wu, K.; Munoz, S.R.; Ellwein, L.B. Visual acuity and quality of life in patients with cataract in Doumen County, China. Ophthalmology 1999, 106, 1609–1615.
  20. Veronese, N.; Honvo, G.; Bruyère, O.; Rizzoli, R.; Barbagallo, M.; Maggi, S.; Smith, L.; Sabico, S.; Al-Daghri, N.; Cooper, C.; et al. Knee osteoarthritis and adverse health outcomes: An umbrella review of meta-analyses of observational studies. Aging Clin. Exp. Res. 2022, 35, 245–252.
  21. Hartnett, D.A.; Milner, J.D.; DeFroda, S.F. Osteoarthritis in the upper extremity. Am. J. Med. 2023, 136, 415–421.
  22. Li, L.; Wang, Z. Ovarian Aging and Osteoporosis. Adv. Exp. Med. Biol. 2018, 1086, 199–215.
  23. Lane, N.E. Epidemiology, etiology, and diagnosis of osteoporosis. Am. J. Obstet. Gynecol. 2006, 194 (Suppl. S2), S3–S11.
  24. Beghé, B.; Cerri, S.; Fabbri, L.M.; Marchioni, A. COPD, Pulmonary fibrosis and ILAs in aging smokers: The paradox of striking different responses to the major risk factors. Int. J. Mol. Sci. 2021, 22, 9292.
  25. Easter, M.; Bollenbecker, S.; Barnes, J.W.; Krick, S. Targeting aging pathways in chronic obstructive pulmonary disease. Int. J. Mol. Sci. 2020, 21, 6924.
  26. Osundolire, S.; Goldberg, R.J.; Lapane, K.L. Descriptive Epidemiology of Chronic Obstructive Pulmonary Disease in US Nursing Home Residents with Heart Failure. Curr. Probl. Cardiol. 2023, 48, 101484.
  27. Macias, R.I.; Monte, M.J.; Serrano, M.A.; González-Santiago, J.M.; Martín-Arribas, I.; Simão, A.L.; Castro, R.E.; González-Gallego, J.; Mauriz, J.L.; Marin, J.J. Impact of aging on primary liver cancer: Epidemiology, pathogenesis and therapeutics. Aging 2021, 13, 23416–23434.
  28. Huntley, C.; Torr, B.; Sud, A.; Rowlands, C.F.; Way, R.; Snape, K.; Hanson, H.; Swanton, C.; Broggio, J.; Lucassen, A.; et al. Utility of polygenic risk scores in UK cancer screening: A modelling analysis. Lancet Oncol. 2023, 24, 658–668.
  29. Kobayashi, L.C.; Westrick, A.C.; Doshi, A.; Ellis, K.R.; Jones, C.R.; LaPensee, E.; Mondul, A.M.; Mullins, M.A.; Wallner, L.P. New directions in cancer and aging: State of the science and recommendations to improve the quality of evidence on the intersection of aging with cancer control. Cancer 2022, 128, 1730–1737.
  30. Kruk, J.; Aboul-Enein, B.H.; Bernstein, J.; Gronostaj, M. Psychological Stress and Cellular Aging in Cancer: A Meta-Analysis. Oxidative Med. Cell. Longev. 2019, 2019, 1270397.
  31. Ness, K.K.; Wogksch, M.D. Frailty and aging in cancer survivors. Transl. Res. 2020, 221, 65–82.
  32. International Diabetes Foundation. Diabetes Facts and Figures. 2022. Available online: https://www.idf.org/about-diabetes/facts-figures/ (accessed on 17 February 2023).
  33. Moghaddam, H.R.; Sobhi, E.; Soola, A.H. Determinants of quality of life among elderly patients with type 2 diabetes in northwest of iran: Based on problem areas in diabetes. Front. Endocrinol. 2022, 13, 924451.
  34. Palarino, J.V.; Boardman, J.D.; Rogers, R.G. Cognition and diabetes: Examining sex differences using a longitudinal sample of older adults. Res. Aging 2022, 45, 161–172.
  35. Ferrer, I. Hypothesis review: Alzheimer’s overture guidelines. Brain Pathol. 2023, 33, e13122.
  36. Choi, S.H.; Tanzi, R.E. Adult neurogenesis in Alzheimer’s disease. Hippocampus 2023, 33, 307–321.
  37. Arsenault-Lapierre, G.; Bui, T.X.; Le Berre, M.; Bergman, H.; Vedel, I. Rural and urban differences in quality of dementia care of persons with dementia and caregivers across all domains: A systematic review. BMC Health Serv. Res. 2023, 23, 102.
  38. Momose, A.; Yamaguchi, S.; Okada, A.; Ikeda-Kurakawa, K.; Namiki, D.; Nannya, Y.; Kato, H.; Yamauchi, T.; Nangaku, M.; Kadowaki, T. Factors associated with long-term care certification in older adults: A cross-sectional study based on a nationally representative survey in Japan. BMC Geriatr. 2021, 21, 374.
  39. De Hert, M.; Detraux, J.; van Winkel, R.; Yu, W.; Correll, C.U. Metabolic and cardiovascular adverse effects associated with antipsychotic drugs. Nat. Rev. Endocrinol. 2011, 8, 114–126.
  40. Meier, T.; Gräfe, K.; Senn, F.; Sur, P.; Stangl, G.I.; Dawczynski, C.; März, W.; Kleber, M.E.; Lorkowski, S. Cardiovascular mortality attributable to dietary risk factors in 51 countries in the WHO European Region from 1990 to 2016: A systematic analysis of the Global Burden of Disease Study. Eur. J. Epidemiol. 2019, 34, 37–55.
  41. Schlesinger, S.; Neuenschwander, M.; Ballon, A.; Nöthlings, U.; Barbaresko, J. Adherence to healthy lifestyles and incidence of diabetes and mortality among individuals with diabetes: A systematic review and meta-analysis of prospective studies. J. Epidemiol. Community Health 2020, 74, 481–487.
  42. Shiroiwa, T.; Noto, S.; Fukuda, T. Japanese Population Norms of EQ-5D-5L and Health Utilities Index Mark 3: Disutility Catalog by Disease and Symptom in Community Settings. Value Health 2021, 24, 1193–1202.
  43. Yang, Z.; Busschbach, J.; Liu, G.; Luo, N. EQ-5D-5L norms for the urban Chinese population in China. Health Qual. Life Outcomes 2018, 16, 210.
  44. Buchholz, I.; Janssen, M.F. EQ-5D-3L Norms for the European Older Population: Country-Specific Norms for 15 European Countires Based on the Survey of Health, Ageing, and Retirement in Europe. Value Health 2022, 26, 721–732.
  45. Ciorba, A.; Bianchini, C.; Pelucchi, S.; Pastore, A. The impact of hearing loss on the quality of life of elderly adults. Clin. Interv. Aging 2012, 7, 159–163.
  46. Lotfi, Y.; Mehrkian, S.; Moossavi, A.; Faghih-Zadeh, S. Quality of life improvement in hearing-impaired elderly people after wearing a hearing aid. Arch. Iran. Med. 2009, 12, 365–370.
  47. Tan, Y.; Liu, L.; Li, J.; Qin, Y.; Sun, A.; Wu, M. Effect of cataract surgery on vision-related quality of life among cataract patients with high myopia: A prospective, case-control observational study. Eye 2022, 36, 1583–1589.
  48. Makabe, K.; Oshika, T.; Inamura, M.; Hayashi, K.; Sugita, G.; Kozawa, T.; Fujishima, K. Influence of cataract surgery for the first or second eye on vision-related quality of life (VR-QOL) and the predictive factors of VR-QOL improvement. Jpn. J. Ophthalmol. 2020, 64, 468–477.
  49. Park, H.-M.; Kim, H.-S.; Lee, Y.-J. Knee osteoarthritis and its association with mental health and health-related quality of life: A nationwide cross-sectional study. Geriatr. Gerontol. Int. 2020, 20, 379–383.
  50. Ruchlin, H.S.; Insinga, R.P. A Review of Health-Utility Data for Osteoarthritis: Implications for clinical trial-based evaluation. Pharmacoeconomics 2008, 26, 925–935.
  51. Tsiligianni, I.; Kocks, J.; Tzanakis, N.; Siafakas, N.; van der Molen, T. Factors that influence disease-specific quality of life or health status in patients with COPD: A systematic review and meta-analysis of Pearson correlations. Prim. Care Respir. J. 2011, 20, 257–268.
  52. Thuppal, S.; Markwell, S.; Crabtree, T.; Hazelrigg, S. Comparison between the EQ-5D-3L and the SF-6D quality of life (QOL) questionnaires in patients with chronic obstructive pulmonary disease (COPD) undergoing lung volume reduction surgery (LVRS). Qual. Life Res. 2019, 28, 1885–1892.
  53. O’Donovan, M.; Sezgin, D.; O’Caoimh, R.; Liew, A. The relationship between frailty and diabetes: An investigation of self-rated health, depression symptoms and quality of life in the Study of Health Aging and Retirement in Europe. Arch. Gerontol. Geriatr. 2021, 96, 104448.
  54. Jia, Z.; Gao, Y.; Zhao, L.; Han, S. Longitudinal relationship between cognitive function and health-related quality of life among middle-aged and older patients with diabetes in China: Digital usage behavior differences. Int. J. Environ. Res. Public Health 2022, 19, 12400.
  55. Carelle, N.; Piotto, E.; Bellanger, A.; Germanaud, J.; Thuillier, A.; Khayat, D. Changing patient perceptions of the side effects of cancer chemotherapy. Cancer 2002, 95, 155–163.
  56. Tucci, M.; Leone, G.; Buttigliero, C.; Zichi, C.; Di Stefano, R.F.; Pignataro, D.; Vignani, F.; Scagliotti, G.V.; Di Maio, M. Hormonal treatment and quality of life of prostate cancer patients: New evidence. Minerva Urol. Nefrol. 2018, 70, 144–151.
  57. Battisti, N.M.L.; Joshi, K.; Nasser, M.S.; Ring, A. Systemic therapy for older patients with early breast cancer. Cancer Treat. Rev. 2021, 100, 102292.
  58. Burks, H.B.; Bordes, J.K.D.; Chadha, R.; Holmes, H.M.; Rianon, N.J. Quality of life assessment in older adults with dementia: A systematic review. Dement. Geriatr. Cogn. Disord. 2021, 50, 103–110.
  59. Monfared, A.A.T.; Byrnes, M.J.; White, L.A.; Zhang, Q. The Humanistic and economic burden of Alzheimer’s disease. Neurol. Ther. 2022, 11, 525–551.
  60. Golicki, D.; Niewada, M.; Buczek, J.; Karlińska, A.; Kobayashi, A.; Janssen, M.F.; Pickard, A.S. Validity of EQ-5D-5L in stroke. Qual. Life Res. 2015, 24, 845–850.
  61. Calvert, M.J.; Freemantle, N.; Cleland, J.G. The impact of chronic heart failure on health-related quality of life data acquired in the baseline phase of the CARE-HF study. Eur. J. Heart Fail. 2005, 7, 243–251.
  62. Arai, H.; Ouchi, Y.; Toba, K.; Endo, T.; Shimokado, K.; Tsubota, K.; Matsuo, S.; Mori, H.; Yumura, W.; Yokode, M.; et al. Japan as the front-runner of super-aged societies: Perspectives from medicine and medical care in Japan. Geriatr. Gerontol. Int. 2015, 15, 673–687.
  63. Münzel, T.; Sørensen, M.; Hahad, O.; Nieuwenhuijsen, M.; Daiber, A. The contribution of the exposome to the burden of cardiovascular disease. Nat. Rev. Cardiol. 2023, 1–19.
More
Video Production Service